The Rise of Colorectal Cancer in Asia: Epidemiology, Screening, and Management

被引：137
作者：
Onyoh E.F. [1 ,2 ,3 ]
Hsu W.-F. [3 ,4 ]
Chang L.-C. [4 ]
Lee Y.-C. [3 ,4 ]
Wu M.-S. [4 ]
Chiu H.-M. [3 ,5 ]
机构：
[1] Institute of Epidemiology and Preventive Medicine, National Taiwan University, Taipei
[2] AIDS Care and Prevention Program, Cameroon Baptist Convention Health Services, Bamenda
[3] Taiwanese Colorectal Cancer Screening Program, Taipei
[4] Department of Internal Medicine, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei
[5] Department of Internal Medicine, College of Medicine, National Taiwan University Hospital, No. 7 Chung-Shan South Road, Taipei
来源：
Current Gastroenterology Reports | 2019年 / 21卷 / 8期
关键词：
Asia; Colonoscopy; Colorectal cancer; Epidemiology; Population; Screening;
D O I：
10.1007/s11894-019-0703-8
中图分类号：
学科分类号：
摘要：
Purpose of Review: Colorectal cancer (CRC) remains the third most commonly diagnosed cancer globally, and its incidence and mortality rates have been on the rise in Asia. In this paper, we summarize the recent trends and screening challenges of CRC in this region. Recent Findings: In 2018, Asia had the highest proportions of both incident (51.8%) and mortality (52.4%) CRC cases (all genders and ages) per 100,000 population in the world. In addition, there has been a rising trend of this disease across Asia with some regional geographic variations. This rise in CRC can be attributed to westernized dietary lifestyle, increasing population aging, smoking, physical inactivity, and other risk factors. In curbing the rising trend, Japan, South Korea, Singapore, and Taiwan have launched nationwide population-based screening programs. CRC screening across this region has been found to be effective and cost-effective compared with no screening at all. The emergence of new therapies has caused a reduction in case fatality; however, these new options have had a limited impact on cure rates and long-term survival due to the great disparity in treatment capacity/resources and screening infrastructures among Asian countries with different degrees of economic development. Summary: CRC is still rising in Asia, and implementation of screening is necessary for moderate- to high-incidence countries and construction of treatment capacity is the priority task in low-incidence and low-income countries. Unless countries in Asia implement CRC screening, the incidence and mortality rates of this disease will continue to rise especially with the rapidly rising population growth, economic development, westernized lifestyle, and increasing aging. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
相关论文
共 91 条
[51]  
Winawer S.J., Zauber A.G., Ho M.N., O'Brien M.J., Gottlieb L.S., Sternberg S.S., Waye J.D., Schapiro M., Bond J.H., Panish J.F., Ackroyd F., Shike M., Kurtz R.C., Hornsby-Lewis L., Gerdes H., Stewart E.T., Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup, N Engl J Med, 329, pp. 1977-1981, (1993)
[52]  
Winawer S.J., Zauber A.G., O'Brien M.J., Ho M.N., Gottlieb L., Sternberg S.S., Waye J.D., Bond J., Schapiro M., Stewart E.T., Panish J., Ackroyd F., Kurtz R.C., Shike M., Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup, N Engl J Med, 328, pp. 901-906, (1993)
[53]  
Zauber A.G., Winawer S.J., O'Brien M.J., Lansdorp-Vogelaar I., van Ballegooijen M., Hankey B.F., Shi W., Bond J.H., Schapiro M., Panish J.F., Stewart E.T., Waye J.D., Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths, N Engl J Med, 366, pp. 687-696, (2012)
[54]  
Cheng S.Y., Li M.C., Chia S.L., Huang K.C., Chiu T.Y., Chan D.C., Chiu H.M., Factors affecting compliance with confirmatory colonoscopy after a positive fecal immunochemical test in a national colorectal screening program, Cancer, 124, pp. 907-915, (2018)
[55]  
Chiu H.M., Chen H.H., Reply to Screening for colorectal cancer in Taiwan and France: does the fecal immunochemical test (FIT) fit?, Cancer, 121, pp. 4442-4443, (2015)
[56]  
Provenzale D., Gray R.N., Colorectal cancer screening and treatment: review of outcomes research, J Natl Cancer Inst Monogr, 2004, pp. 45-55, (2004)
[57]  
Nishihara R., Wu K., Lochhead P., Morikawa T., Liao X., Qian Z.R., Inamura K., Kim S.A., Kuchiba A., Yamauchi M., Imamura Y., Willett W.C., Rosner B.A., Fuchs C.S., Giovannucci E., Ogino S., Chan A.T., Long-term colorectal-cancer incidence and mortality after lower endoscopy, N Engl J Med, 369, pp. 1095-1105, (2013)
[58]  
Ahmed F., Barriers to colorectal cancer screening in the developing world: the view from Pakistan, World J Gastrointest Pharmacol Ther, 4, pp. 83-85, (2013)
[59]  
Gelband H., Jha P., Sankaranarayanan R., Horton S., Bank W., Disease control priorities, 3, (2015)
[60]  
Hyodo I., Suzuki H., Takahashi K., Saito Y., Tanaka S., Chiu H.M., Kim N.K., Li J., Lim R., Villalon A., Boku N., Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference, Jpn J Clin Oncol, 40, pp. i38-i43, (2010)
12345678910